J Trabanino
Gastroenterology · Sugar Land, TXNPI 1669473690
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 209 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,780 and has fallen 92.7% since, to $130 in 2022. That places this record below the midpoint for gastroenterology clinicians in TX, where the typical reported total is $3,104.
Across 209 payments — averaging $18.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$815
- Takeda Pharmaceuticals U.S.A., Inc.$743
- Johnson & Johnson$725
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$506
- Nestle Healthcare Nutrition Inc.$187
- Redhill Biopharma Inc.$167
- plus $665 from 14 others
What the payments were for
- Food & beverage$3,71998%
- Education$892%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 36 | $815 |
| Takeda Pharmaceuticals U.S.A., Inc. | 45 | $743 |
| Johnson & Johnson | 42 | $725 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 30 | $506 |
| Nestle Healthcare Nutrition Inc. | 8 | $187 |
| Redhill Biopharma Inc. | 9 | $167 |
| Bristol Myers Squibb | 10 | $150 |
| Merck | 7 | $146 |
| Pfizer | 6 | $93 |
| Concordia Pharmaceuticals Inc. | 1 | $53 |
| Braintree Laboratories, Inc. | 3 | $48 |
| Ferring Pharmaceuticals Inc. | 3 | $42 |
| Intercept Pharmaceuticals, Inc. | 2 | $33 |
| Alfasigma USA, Inc. | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Organon | 1 | $16 |
| Cumberland Pharmaceuticals, Inc. | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $13 |
| Gilead | 1 | $12 |
| QOL Medical, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIFAXAN$100
How this compares
$3,808 in reported general payments places this provider in the 50th percentile of 1,350 gastroenterology providers in Texas.
Other gastroenterology in Sugar Land
- Charles PhanSugar Land$139K
- John FordtranDallas$9.9M
- Michael BrownDallas$5.5M
- Bincy AbrahamHouston$1.6M
- Mazen NoureddinHouston$1.5M
- Stephen PappasHouston$1.4M
- Anish PatelFort Sam Houston$1.3M
- Timothy RitterSouthlake$961K
- Parvez MantryDallas$958K
- Nadege GunnWaco$933K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.